A Landmark in Cardiac Innovation

Yashoda Hospitals Successfully Performs ICE & NavX-Guided Cryoablation for Atrial Fibrillation

Yashoda Hospitals has achieved a groundbreaking milestone as the Department of Cardiology successfully performed cryoablation for atrial fibrillation, guided by Intracardiac Echocardiography (ICE) and NavX 3D Mapping. This pioneering procedure marks a first-of-its-kind advancement in both Telangana and Andhra Pradesh, setting a new standard in the treatment of complex cardiac arrhythmias.

Cryoablation, which utilizes a cryoballoon catheter to freeze arrhythmogenic tissue, has emerged as a highly effective and increasingly preferred treatment modality for patients with paroxysmal and persistent atrial fibrillation (AFib).

Cryoablation: A Targeted Approach to Pulmonary Vein Isolation

Cryoablation employs a balloon catheter to deliver cryothermal energy, creating durable lesions by freezing the myocardial tissue responsible for triggering and sustaining AFib. This approach allows for a more homogeneous lesion set and often results in shorter procedure times and reduced patient discomfort compared to traditional radiofrequency ablation.

ICE and NavX: Enhancing Safety, Accuracy, and Outcomes

ICE provides real-time, high-resolution intracardiac imaging, enabling accurate visualization of cardiac anatomy and catheter positioning. It plays a crucial role in guiding transseptal puncture and continuous monitoring during ablation.

The NavX Mapping System offers radiation-free, three-dimensional mapping of the heart’s electrical activity. This advanced system allows electrophysiologists to localize arrhythmogenic foci and optimize catheter navigation without fluoroscopy.

ICE and NavX-Guided Cryoablation in Persistent AFib

In complex and persistent AFib cases, where substrate modification is often necessary, the use of ICE and NavX becomes even more critical. These technologies facilitate precise targeting of non-pulmonary vein triggers and areas of atrial remodeling, enhancing procedural success while minimizing complications.

Clinical Advantages for Patients:

• Reduced radiation exposure
• Enhanced procedural accuracy
• Minimally invasive and well-tolerated
• Superior efficacy compared to drug therapy

This milestone underscores Yashoda Hospitals’ commitment to innovation in cardiac care. By integrating cutting-edge technology with clinical excellence, the team has achieved a significant breakthrough in the management of atrial fibrillation—enhancing precision, improving patient outcomes, and reducing procedural risks.